Margarite buys MRK 60.1: Achillion-Janssen Deal Boosts Achillion's Progress In Competing In Hepatitis-C
“to a triple regimen which is being tested by a number of companies like Gilead and Merck (NYSE:MRK). The three compounds that can be combined are a NS5A inhibitor, a NS5B nucleotide, and an NS3/4A Protease inhibitor. The possible structures of HCV …” said Talia to Yuko on Friday, May 22, 2015.
“My dear Miss Yuko,” said Talia, “have you heard that HSI went up to 27523.72?”
“Hang Seng Index.”
Yuko replied that she had not.
“But it did,” said Talia. “Hong Kong stocks end 0.39pc weaker, Hang Seng drops 108.49pts The benchmark Hang Seng Index on Wednesday dropped 108.49 points to close at 27,585.05 on turnover of $HK137.78 billion ($A22.46 billion). But the benchmark Shanghai Composite Index gained 0.65 per cent, or 28.74 points, to 4,446.29 on turnover of 806.1 ..”
Yuko, with good-humored countenance, made no answer.